Stem cells from Parkinson’s disease patients
Nature Communications
August 24, 2011
The production of induced pluripotent stem cells from the skin cells of a Parkinson’s disease patient mimic the features of the disease reports a paper published in Nature Communications this week. These cells can be used to study the disease more accurately and may aid in the identification of compounds that can reduce the expression of proteins responsible for the disease.
Michael Devine, Tilo Kunath and colleagues, used skin cells from a patient with familial Parkinson’s disease that carries elevated copies of the gene alpha-synuclein. The cells were used to generate induced pluripotent stem cells that could then be differentiated into neurons. The resulting neurons produced twice the amount of alpha-synuclein compared to cells from an unaffected family member, demonstrating that features of the disease were retained in the neurons. These cells may aid in the discovery of the mechanisms that lead to Parkinson’s disease and may permit the identification of compounds that can reduce alpha-synuclein levels.
doi: 10.1038/ncomms1453
Research highlights
-
Jun 24
Palaeontology: It sucked to be the prey of ancient cephalopodsScientific Reports
-
Jun 24
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
Jun 23
Scientific community: Women credited less than men in scientific paper authorshipNature
-
Jun 17
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
Jun 17
Conservation: Feral cats pushing critically endangered marsupial further towards extinctionScientific Reports
-
Jun 16
Microbiology: DNA analysis indicates origins of the Black DeathNature